Galecto - 53 Year Dividend History | GLTO
Historical dividend payout and yield for Galecto (GLTO) since 1971. The current TTM dividend payout for Galecto (GLTO) as of November 29, 2024 is $0.00. The current dividend yield for Galecto as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.007B |
$0.000B |
|
Galecto Inc. is a clinical stage biotechnology company with advanced programs in fibrosis and cancer centered on galectin-3 and LOXL2. The Company's pipeline includes an inhaled galectin-3 modulator currently in Phase 2b for the potential treatment of idiopathic pulmonary fibrosis. Galecto Inc. is headquarters in Copenhagen, Denmark.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
